T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection. 2017

Lúcia Moreira-Teixeira, and Paul S Redford, and Evangelos Stavropoulos, and Nico Ghilardi, and Craig L Maynard, and Casey T Weaver, and Ana Paula Freitas do Rosário, and Xuemei Wu, and Jean Langhorne, and Anne O'Garra
Laboratory of Immunoregulation and Infection, The Francis Crick Institute, London NW1 1AT, United Kingdom; lucia.teixeira@crick.ac.uk.

Tuberculosis (TB), caused by Mycobacterium tuberculosis infection, is a leading cause of mortality and morbidity, causing ∼1.5 million deaths annually. CD4+ T cells and several cytokines, such as the Th1 cytokine IFN-γ, are critical in the control of this infection. Conversely, the immunosuppressive cytokine IL-10 has been shown to dampen Th1 cell responses to M. tuberculosis infection impairing bacterial clearance. However, the critical cellular source of IL-10 during M. tuberculosis infection is still unknown. Using IL-10 reporter mice, we show in this article that during the first 14 d of M. tuberculosis infection, the predominant cells expressing IL-10 in the lung were Ly6C+ monocytes. However, after day 21 postinfection, IL-10-expressing T cells were also highly represented. Notably, mice deficient in T cell-derived IL-10, but not mice deficient in monocyte-derived IL-10, showed a significant reduction in lung bacterial loads during chronic M. tuberculosis infection compared with fully IL-10-competent mice, indicating a major role for T cell-derived IL-10 in TB susceptibility. IL-10-expressing cells were detected among both CD4+ and CD8+ T cells, expressed high levels of CD44 and Tbet, and were able to coproduce IFN-γ and IL-10 upon ex vivo stimulation. Furthermore, during M. tuberculosis infection, Il10 expression in CD4+ T cells was partially regulated by both IL-27 and type I IFN signaling. Together, our data reveal that, despite the multiple immune sources of IL-10 during M. tuberculosis infection, activated effector T cells are the major source accounting for IL-10-induced TB susceptibility.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000950 Antigens, Ly A group of lymphocyte surface antigens located on mouse LYMPHOCYTES. Specific Ly antigens are useful markers for distinguishing subpopulations of lymphocytes. Ly Antigens
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D016753 Interleukin-10 A cytokine produced by a variety of cell types, including T-LYMPHOCYTES; MONOCYTES; DENDRITIC CELLS; and EPITHELIAL CELLS that exerts a variety of effects on immunoregulation and INFLAMMATION. Interleukin-10 combines with itself to form a homodimeric molecule that is the biologically active form of the protein. IL-10,CSIF-10,Cytokine Synthesis Inhibitory Factor,IL10,Interleukin 10

Related Publications

Lúcia Moreira-Teixeira, and Paul S Redford, and Evangelos Stavropoulos, and Nico Ghilardi, and Craig L Maynard, and Casey T Weaver, and Ana Paula Freitas do Rosário, and Xuemei Wu, and Jean Langhorne, and Anne O'Garra
July 1998, Clinical and experimental immunology,
Lúcia Moreira-Teixeira, and Paul S Redford, and Evangelos Stavropoulos, and Nico Ghilardi, and Craig L Maynard, and Casey T Weaver, and Ana Paula Freitas do Rosário, and Xuemei Wu, and Jean Langhorne, and Anne O'Garra
November 2016, Scientific reports,
Lúcia Moreira-Teixeira, and Paul S Redford, and Evangelos Stavropoulos, and Nico Ghilardi, and Craig L Maynard, and Casey T Weaver, and Ana Paula Freitas do Rosário, and Xuemei Wu, and Jean Langhorne, and Anne O'Garra
November 2021, JCI insight,
Lúcia Moreira-Teixeira, and Paul S Redford, and Evangelos Stavropoulos, and Nico Ghilardi, and Craig L Maynard, and Casey T Weaver, and Ana Paula Freitas do Rosário, and Xuemei Wu, and Jean Langhorne, and Anne O'Garra
November 2018, Nature microbiology,
Lúcia Moreira-Teixeira, and Paul S Redford, and Evangelos Stavropoulos, and Nico Ghilardi, and Craig L Maynard, and Casey T Weaver, and Ana Paula Freitas do Rosário, and Xuemei Wu, and Jean Langhorne, and Anne O'Garra
April 2017, Biochemical and biophysical research communications,
Lúcia Moreira-Teixeira, and Paul S Redford, and Evangelos Stavropoulos, and Nico Ghilardi, and Craig L Maynard, and Casey T Weaver, and Ana Paula Freitas do Rosário, and Xuemei Wu, and Jean Langhorne, and Anne O'Garra
January 1997, Journal of immunology (Baltimore, Md. : 1950),
Lúcia Moreira-Teixeira, and Paul S Redford, and Evangelos Stavropoulos, and Nico Ghilardi, and Craig L Maynard, and Casey T Weaver, and Ana Paula Freitas do Rosário, and Xuemei Wu, and Jean Langhorne, and Anne O'Garra
March 2019, Journal of virology,
Lúcia Moreira-Teixeira, and Paul S Redford, and Evangelos Stavropoulos, and Nico Ghilardi, and Craig L Maynard, and Casey T Weaver, and Ana Paula Freitas do Rosário, and Xuemei Wu, and Jean Langhorne, and Anne O'Garra
February 2020, Journal of immunology (Baltimore, Md. : 1950),
Lúcia Moreira-Teixeira, and Paul S Redford, and Evangelos Stavropoulos, and Nico Ghilardi, and Craig L Maynard, and Casey T Weaver, and Ana Paula Freitas do Rosário, and Xuemei Wu, and Jean Langhorne, and Anne O'Garra
February 2018, Journal of leukocyte biology,
Lúcia Moreira-Teixeira, and Paul S Redford, and Evangelos Stavropoulos, and Nico Ghilardi, and Craig L Maynard, and Casey T Weaver, and Ana Paula Freitas do Rosário, and Xuemei Wu, and Jean Langhorne, and Anne O'Garra
May 2024, JCI insight,
Copied contents to your clipboard!